FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2783986018> ?p ?o ?g. }

• W2783986018 endingPage "27584" @default.
• W2783986018 startingPage "27574" @default.
• W2783986018 abstract "// Xiaogang Sun 1 , Shuhong Huang 2 , Xin Wang 3 , Xiaohua Zhang 1 and Xin Wang 1 1 Shandong Provincial Hospital Affiliated to Shandong University, Jinan, P.R. China 2 Department of Neurobiology, Key Laboratory of Medical Neurobiology, School of Medicine, Shandong University, Jinan, Shandong, P.R. China 3 Tengzhou Municipal Hospital of Traditional Chinese Medicine, Tengzhou, Shandong, P.R. China Correspondence to: Xin Wang, email: Wangxin20120916@163.com Keywords: CD300A; PECAM1; ADCY7; acute myeloid leukemia; U937 Received: August 24, 2017      Accepted: December 01, 2017      Epub: January 11, 2018      Published: June 08, 2018 ABSTRACT CD300A is a member of the CD300 glycoprotein family of cell surface proteins involved in immune response signaling pathways. There is evidence that CD300A plays a role in autophagy and angiogenesis, while, no studies have been reported which investigated the role of CD300A in tumors. CD300A was found to be highly expressed with statistical significance in acute myeloid leukemia (AML), as well as associated with prognosis, through the analysis of differential expression genes using the TCGA and GTEx database. A decrease in CD300A expression could promote apoptosis and inhibit proliferation and migration of AML cell line U937, as well as promote the activation of the AKT/mTOR pathway. These results demonstrated that CD300A operated as a tumor promoter in AML cells. We further analyzed coexpression genes of CD300A and then screened two genes, ADCY7 and PECAM1, which were both overexpressed and associated with poor prognosis in AML. Meanwhile, CD300A increased the expression of PECAM1 and ADCY7 in U937 cells. Furthermore, we demonstrated that PECAM1 promoted the proliferation and migration and inhibited the apoptosis of U937 cells. ADCY7 participated in the regulation of proliferation and migration, but not apoptosis, in U937 cells. Both PECAM1 and ADCY7 promoted tumor progression through the AKT pathway, showing the same molecular mechanism as CD300A. To summarize, we, for the first time, confirmed that CD300A promoted tumor progression by increase PECAM1 and ADCY7 expression, and activating the AKT/mTOR signaling pathway in AML. It is suggested CD300A is an oncogene and potential therapeutic target for AML." @default.
• W2783986018 created "2018-01-26" @default.
• W2783986018 creator A5005241892 @default.
• W2783986018 creator A5006822602 @default.
• W2783986018 creator A5075141173 @default.
• W2783986018 creator A5079969251 @default.
• W2783986018 date "2018-01-11" @default.
• W2783986018 modified "2023-09-27" @default.
• W2783986018 title "CD300A promotes tumor progression by PECAM1, ADCY7 and AKT pathway in acute myeloid leukemia" @default.
• W2783986018 cites W1224756471 @default.
• W2783986018 cites W1454504028 @default.
• W2783986018 cites W1492609361 @default.
• W2783986018 cites W1643432417 @default.
• W2783986018 cites W1977085566 @default.
• W2783986018 cites W2003325833 @default.
• W2783986018 cites W2009886857 @default.
• W2783986018 cites W2023708006 @default.
• W2783986018 cites W2028715061 @default.
• W2783986018 cites W2055872555 @default.
• W2783986018 cites W2074677800 @default.
• W2783986018 cites W2080776128 @default.
• W2783986018 cites W2083827528 @default.
• W2783986018 cites W2090543914 @default.
• W2783986018 cites W2115313536 @default.
• W2783986018 cites W2115395854 @default.
• W2783986018 cites W2131888987 @default.
• W2783986018 cites W2134625151 @default.
• W2783986018 cites W2151928790 @default.
• W2783986018 cites W2153909067 @default.
• W2783986018 cites W2170846829 @default.
• W2783986018 cites W2177456672 @default.
• W2783986018 cites W2214601177 @default.
• W2783986018 cites W2334644139 @default.
• W2783986018 cites W2407516144 @default.
• W2783986018 cites W2419140434 @default.
• W2783986018 cites W2550553009 @default.
• W2783986018 cites W2607129810 @default.
• W2783986018 doi "https://doi.org/10.18632/oncotarget.24164" @default.
• W2783986018 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6007949" @default.
• W2783986018 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29938007" @default.
• W2783986018 hasPublicationYear "2018" @default.
• W2783986018 type Work @default.
• W2783986018 sameAs 2783986018 @default.
• W2783986018 citedByCount "11" @default.
• W2783986018 countsByYear W27839860182018 @default.
• W2783986018 countsByYear W27839860182020 @default.
• W2783986018 countsByYear W27839860182021 @default.
• W2783986018 countsByYear W27839860182022 @default.
• W2783986018 countsByYear W27839860182023 @default.
• W2783986018 crossrefType "journal-article" @default.
• W2783986018 hasAuthorship W2783986018A5005241892 @default.
• W2783986018 hasAuthorship W2783986018A5006822602 @default.
• W2783986018 hasAuthorship W2783986018A5075141173 @default.
• W2783986018 hasAuthorship W2783986018A5079969251 @default.
• W2783986018 hasBestOaLocation W27839860181 @default.
• W2783986018 hasConcept C2778729363 @default.
• W2783986018 hasConcept C2779282312 @default.
• W2783986018 hasConcept C2780394083 @default.
• W2783986018 hasConcept C502942594 @default.
• W2783986018 hasConcept C54355233 @default.
• W2783986018 hasConcept C62478195 @default.
• W2783986018 hasConcept C71924100 @default.
• W2783986018 hasConcept C75217442 @default.
• W2783986018 hasConcept C86554907 @default.
• W2783986018 hasConcept C86803240 @default.
• W2783986018 hasConceptScore W2783986018C2778729363 @default.
• W2783986018 hasConceptScore W2783986018C2779282312 @default.
• W2783986018 hasConceptScore W2783986018C2780394083 @default.
• W2783986018 hasConceptScore W2783986018C502942594 @default.
• W2783986018 hasConceptScore W2783986018C54355233 @default.
• W2783986018 hasConceptScore W2783986018C62478195 @default.
• W2783986018 hasConceptScore W2783986018C71924100 @default.
• W2783986018 hasConceptScore W2783986018C75217442 @default.
• W2783986018 hasConceptScore W2783986018C86554907 @default.
• W2783986018 hasConceptScore W2783986018C86803240 @default.
• W2783986018 hasIssue "44" @default.
• W2783986018 hasLocation W27839860181 @default.
• W2783986018 hasLocation W27839860182 @default.
• W2783986018 hasLocation W27839860183 @default.
• W2783986018 hasLocation W27839860184 @default.
• W2783986018 hasOpenAccess W2783986018 @default.
• W2783986018 hasPrimaryLocation W27839860181 @default.
• W2783986018 hasRelatedWork W1984461699 @default.
• W2783986018 hasRelatedWork W1988747615 @default.
• W2783986018 hasRelatedWork W2060953522 @default.
• W2783986018 hasRelatedWork W2074251257 @default.
• W2783986018 hasRelatedWork W2104683328 @default.
• W2783986018 hasRelatedWork W2376211306 @default.
• W2783986018 hasRelatedWork W2383760525 @default.
• W2783986018 hasRelatedWork W2936372113 @default.
• W2783986018 hasRelatedWork W3006030203 @default.
• W2783986018 hasRelatedWork W4312127270 @default.
• W2783986018 hasVolume "9" @default.
• W2783986018 isParatext "false" @default.
• W2783986018 isRetracted "false" @default.
• W2783986018 magId "2783986018" @default.
• W2783986018 workType "article" @default.